Fig. 1From: Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysisForest plot reflects the association between TKIs -induced hypertension and oncologic outcomes (progression free survival) in different TKIs subgroups (1: axitinib; 2: sorafenib; 3: sunitinib; 4: pazopanib)Back to article page